MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner

Now, MD Anderson has emerged with some of the first clinical proof this can work. A team led by Katayoun Rezvani attached CARs – chimeric antigen receptors – for CD19 to natural killer cells and injected them into 11 patients with either non-Hodgkin lymphoma or chronic lymphocytic leukemia. Seven of them had a complete response; their tumors vanished.